Target intelligence / Profile preview

Lectin-binding carbohydrate moiety

Molecular classification
Other
01

Overview

A **lectin-binding carbohydrate moiety** refers to any carbohydrate structure (glycan or oligosaccharide motif) on the surface of cells or glycoproteins that is recognized and reversibly bound by a lectin via its carbohydrate recognition domain (CRD)[1][4]. These carbohydrate motifs usually consist of 1–4 monosaccharide units and present specific structures, such as high-mannose, complex N-glycans, sialylated, galactosylated, or GlcNAc-containing motifs, that determine lectin-binding specificity[1][2][3]. Lectin-glycan interactions are critical in a variety of biological processes, including cell–cell recognition, signaling, immune responses, host–pathogen interactions, and plant–microbe symbiosis[1][3][4]. The carbohydrate portion is not a standalone protein, gene, or canonical receptor but refers to the molecular structure or epitope recognized by lectins[1][4]. **Key context:** - The phrase is **not** the name of a protein, receptor, or traditional drug target. - There are no abbreviations or drug-targeting mechanisms associated with this generic glycan term. - Specific examples of lectin-binding carbohydrate motifs include high-mannose glycans, GlcNAc-containing trimers (recognized by Nictaba lectin), galactosyl or sialyl motifs, etc.[1][2][3] - Lectins themselves may be therapeutic targets or tools, but the glycan motifs they bind are not commonly targeted by drugs directly—they can be targets for glycosylation pathway inhibitors or for diagnostic purposes.

Other names
Glycan ligandLectin ligandCarbohydrate epitopeGlycan motifLectin-recognized carbohydrate
02

Biological functions

Structural componentCell-cell recognitionSignal modulation
03

Disease associations

Other (glycan motifs play roles in infection, inflammation, and cancer via lectin interactions, but the motif itself is not the direct target)

Beyond the preview

Go deeper on Lectin-binding carbohydrate moiety.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Lectin-binding carbohydrate moiety.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call